InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Sullivan Tiffany, Director. Director active across 1 company, notably Pulmonx Corp. Cumulatively, 5 disclosures have been published. Activity tracked since 1 September 2021. The latest transaction was filed on 3 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Tiffany Sullivan is a Director at Pulmonx Corp. In this role, she contributes to the company's strategy and oversight of operations. Her expertise in the medical sector is essential for Pulmonx's development.